
2.60 BATS BZX Real-Time Price As of 10:38am ET | ![]() Today’s Change | 1.43 Today|||52-Week Range 4.68 | +34.72% Year-to-Date |
The 6 analysts offering 12-month price forecasts for Trevi Therapeutics Inc have a median target of 7.50, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +188.46% increase from the last price of 2.60.
The current consensus among 6 polled investment analysts is to Buy stock in Trevi Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.